Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Harika Dinc"'
Autor:
Harika Dinc, Utku Cizmecigil, Cem Sulu, Suleyman Yildirim, Sezgin Uludag, Basar Turgut, Serhat Sirekbasan, Okan Aydogan, Tunahan Durman, Dogukan Ozbey, Beyza Aslan, Abdullah Sonsuz, Kagan Zengin, Volkan Yumuk, Aysun Yilmaz, Nuri Turan, Huseyin Yilmaz, Banu Kocak, Suat Saribas, Sevgi Ergin, Bekir Kocazeybek
Publikováno v:
Clinical Laboratory. 69
Background: HAdV-36 leads to adipocyte proliferation of adipose tissue through E4orf1 gene, leading to the development of obesity and related diseases. We aimed to investigate the presence and any association of HAdV-36 in non-alcoholic fatty liver d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce2fd8d50828b633c480c1cfdda82e2
https://doi.org/10.7754/clin.lab.2022.221031
https://doi.org/10.7754/clin.lab.2022.221031
Autor:
Halit Tokman, Sevgi Ergin, Suat Saribas, Harika Dinc, Mahir Cengiz, Serap Yavuzer, Utku Cizmecigil, Nuri Onder, Huseyin Yilmaz, Onder Eryigit, Nesrin Gareayaghi, Bekir Kocazeybek
Publikováno v:
Clinical laboratory. 68(11)
Obesity may also develop due to a viral infection caused by adenovirus 36. We aimed to detect the presence of neutralizing antibodies against Ad-36 in adult patients who developed type 2 diabetes due to obesity (BMI ≥ 30 kg/m2).The patient group (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04d0c0f93dad12e1d5a53bddaaf0c7c
https://pubmed.ncbi.nlm.nih.gov/36377995
https://pubmed.ncbi.nlm.nih.gov/36377995
Autor:
Ridvan Karaali, Harika Dinc, Yusuf Ozdemir, Zeynep Dalar, Ahmet Kurt, Ayse Aktas, Serhat Sirekbasan, Yesim Tok, Mert Kuskucu, Ilker Balkan, Bilgul Mete, Gokhan Aygun, Kenan Midilli, Suat Saribas, Nese Saltoglu, Huseyin Cakan, Bekir Kocazeybek
Publikováno v:
Clinical Laboratory. 68
COVID-19 causes clinical manifestations ranging from asymptomatic infection to multi-organ failure. It is reported that those with severe disease have higher anti-SARS-CoV-2 antibody titers compared to asymptomatic or mild cases. We evaluated the cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7768223384e943c67d66ebea38718ec2
https://doi.org/10.7754/clin.lab.2021.211230
https://doi.org/10.7754/clin.lab.2021.211230
Publikováno v:
Diabetes Week; 2/6/2023, p1128-1128, 1p